Trial NCT03970616

View at ClinicalTrials.gov 
Org. Study IDs: AV-951-18-121

Last trial update was posted on 2023-07-12

MeSH Interventions

Durvalumab Tivozanib

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Hepatocellular Carcinoma

Stopping Reasons

The study was terminated due to regulatory approval of newer therapeutic options and slower than anticipated accrual.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID